The increase of bacterial resistance to existing antibacterial therapies combined with the decrease of research on new antibacterial drugs has led to a serious public health crisis. Antibacterial drug development (ABDD) is a long and costly process due to complex protocols, difficulties with enrolling subjects, completing trials, and analyzing the results.
Read more about the ABDD program, and the projects within this program.
Digital Health Trials (DHT)
Digital health trials offer the potential to increase the quality and efficiency of clinical trials 1) by allowing participants to participate remotely for some or all study activities, and 2) by creating opportunities to develop novel endpoints.